natgillin/translations-raw huggingface dataset:
a medicine called nefazodone used to treat depression
zdravilo, ki ga imenujemo nefazodon in ga uporabljamo za zdravljenje depresije,
a medicine called penicillamine used to treat rheumatoid arthritis a herbal medicine called St. John’s wort (also known as Hypericum perforatum) used to treat depression.
zdravilo, ki ga imenujemo penicilamin in ga uporabljamo za zdravljenje revmatoidnega artritisa, zdravilo rastlinskega izvora z imenom šentjanževka (imenujemo jo tudi Hypericum perforatum), ki ga uporabljamo za zdravljenje depresije.
a medicine containing theophylline (a medicine to treat respiratory diseases), or
zdravilo, ki vsebuje teofilin (zdravilo za zdravljenje bolezni dihal),
A medicine cup with graduation markings at 20, 40, 60 and 80 ml
lonček za zdravilo z oznakami za 20, 40, 60 in 80 ml
a medicine for diarrhoea called kaolin. tricyclic antidepressants (such as fluoxetine), antihistamines (such as cetirizine, fexofenadine)
zdravilo proti driski imenovano kaolin triciklične antidepresive (kot je fluoksetin), antihistaminike (kot sta cetirizin, feksofenadin).
a medicine for epilepsy as any changes in the frequency and severity of your convulsions should be discussed with your doctor. medicines to treat HIV.
zdravila za zdravljenje epilepsije; vsako spremembo v pogostnosti in jakosti krčev sporočite vašemu zdravniku. zdravila za zdravljenje okužb z virusom HIV.
a medicine to treat cancer (interferon alpha)
interferon alfa za zdravljenje raka
a medicine used for treatment of immunological diseases, such as methotrexate, azathioprine, infliximab, etanercept, or oral corticosteroids to be taken long-term. a medicine containing fluvoxamine (a medicine to treat anxiety disorders and depression), enoxacin (a medicine to treat bacterial infections) or cimetidine (a medicine to treat stomach ulcers or heartburn).
zdravila, ki se uporabljajo za zdravljenje bolezni imunskega sistema, kot so metotreksat, azatioprin, infliksimab, etanercept ali peroralni kortikosteroidi, ki jih jemljete dolgotrajno, zdravilo, ki vsebuje fluvoksamin (zdravilo za zdravljenje tesnobe in depresije), enoksacin (zdravilo za zdravljenje bakterijskih okužb) ali cimetidin (zdravilo za zdravljenje želodčnih razjed ali zgage).
a medicine used to treat bacterial infections (erythromycin) a medicine that affects your immune system (cyclosporine)
zdravilo za zdravljenje bakterijskih okužb (eritromicin) zdravilo, ki vpliva na imunski sistem (ciklosporin)
a medicine used to treat fungal infections (ketoconazole)
zdravilo za zdravljenje glivičnih okužb (ketokonazol)
A membrane capacitor connected with this chamber, which is exposed to a high resistance direct voltage, transforms these pressure fluctuations into an alternating voltage, which is a measure of the isotopic composition of breath carbon dioxide.
Membranski kondenzator, ki je povezan s to komoro in izpostavljen neposredni napetosti z visokim uporom, spremeni to nihanje pritiska v izmenično napetost, ki je merilo za izotopno sestavo ogljikovega dioksida v izdihanem zraku.
A meta-analysis from 54 epidemiological studies reported that there is a slightly increased relative risk (RR = 1.24) of having breast cancer diagnosed in women who are currently using COCs.
Po meta-analizi 54 epidemioloških študij so poročali o rahlo povečanem relativnem tveganju (RR = 1,24), da bodo pri ženski, ki trenutno jemlje COC, odkrili rak dojke.
A meta-analysis from 54 epidemiological studies reported that there is a slightly increased relative risk (RR = 1.24) of having breast cancer diagnosed in women who are currently using COCs.
Po meta-analizi 54 epidemioloških študij so poročali o rahlo povečanem relativnem tveganju (RR = 1,24), da bodo pri ženski, ki trenutno jemlje KPK, odkrili rak dojke.
A meta-analysis of 14 clinical trials with data from over 4700 patients treated with capecitabine monotherapy or capecitabine in combination with different chemotherapy regimens in multiple indications (colon, colorectal, gastric and breast cancer) showed that patients on capecitabine who developed hand-foot syndrome (HFS) had a longer overall survival compared to patients who did not develop HFS: median overall survival 1100 days (95% CI 1007;1200) vs 691 days (95% CI 638;754) with a hazard ratio of 0.61 (95% CI 0.56;
Meta-analiza 14 kliničnih preskušanj s podatki od več kot 4.700 bolnikov, zdravljenih s kapecitabinom samim ali v kombinaciji z različnimi shemami kemoterapije pri več indikacijah (rak kolona, kolorektalni rak, rak želodca in rak dojk) je pokazala, da so imeli bolniki, pri katerih se je razvil sindrom roka-noga, daljše celokupno preživetje v primerjavi z bolniki, ki niso imeli tega sindroma; mediana celokupnega preživetja je bila 1.100 dni (95-% interval zaupanja; 1.007; 1.200) v primerjavi s 691 dnevi (95-% interval zaupanja 638; 754) z razmerjem ogroženosti 0,61 (95-% interval zaupanja;
A meta-analysis of 15 clinical trials of ≥ 12 weeks treatment duration, including 7002 patients (4190 CHAMPIX, 2812 placebo), was conducted to systematically assess the cardiovascular safety of CHAMPIX.
Meta analiza 15 kliničnih preskušanj, pri katerih je zdravljenje trajalo ≥ 12 tednov, v njih pa sta bila vključena 7002 bolnika (4190 CHAMPIX, 2812 placebo), je bila opravljena z namenom sistematične ocene srčnožilne varnosti zdravila CHAMPIX.
A meta-analysis of 5 randomised, double blind, placebo controlled trials, including 1907 patients (1130 varenicline, 777 placebo), was conducted to assess suicidal ideation and behaviour as reported on the Columbia-Suicide Severity Rating Scale (C-SSRS).
Opravili so meta analizo 5 randomiziranih, dvojno slepih, s placebom nadzorovanih preskušanj, ki so vključevala 1.907 bolnikov (1.130 vareniklin, 777 placebo), s katero so ocenili samomorilne misli in vedenje, kot so o njiju poročali po lestvici C-SSRS.
A meta-analysis of 9 clinical studies (8 major effectiveness studies and 1 phase II dose finding study) of up to 3 years duration was conducted to assess the cardiovascular safety of Eperzan (N=2,524) compared to all comparators (N=2,583) within these trials.
Opravili so metaanalizo 9 kliničnih študij (8 velikih študij učinkovitosti in 1 študija II. faze za določitev odmerka), ki so trajale do 3 let, za oceno kardiovaskularne varnosti zdravila Eperzan (N = 2.524) v primerjavi z vsemi primerjalnimi zdravili (N = 2.583) v teh preskušanjih.
A meta-analysis of allogeneic transplant studies, including the results of nine prospective randomized trials, eight retrospective studies and one case-controlled study, did not detect an effect on the risks of acute GvHD, chronic GvHD or early treatment-related mortality.
Meta analiza študij pri alogenih presaditvah, vključno z rezultati devetih prospektivnih randomiziranih preskušanj, osem retrospektivnih študij in ena s primerom nadzorovana študija, niso zaznale vpliva na tveganje za pojav akutne reakcije presadka proti gostitelju (GvHD), kronične reakcije presadka proti gostitelju, in zgodnje, z zdravljenjem povezane smrtnosti.
A meta-analysis of patients with moderate to severe Alzheimer’s disease (MMSE total scores < 20) from the six phase III, placebo-controlled, 6-month studies (including monotherapy studies and studies with patients on a stable dose of acetylcholinesterase inhibitors) showed that there was a statistically significant effect in favour of memantine treatment for the cognitive, global, and functional domains.
Metaanaliza bolnikov z zmerno do hudo Alzheimerjevo boleznijo (skupna ocena pri KPSS ob vključitvi < 20 točk), ki je zajela šest študij III. faze, kontroliranih s placebom in trajajočih šest mesecev (vključno s študijami zdravljenja v monoterapiji ter študijami bolnikov, ki so dobivali stabilni odmerek zaviralcev acetilholinesteraze), je pokazala statistično značilen učinek v korist zdravljenja z memantinom pri spoznavnih funkcijah ter globalnih in funkcionalnih področjih.
A meta-analysis of placebo- controlled clinical trials of antidepressant medicinal products in psychiatric disorders showed an increased risk of suicidal behaviour with antidepressants compared to placebo in patients less than 25 years old.
Metaanaliza s placebom nadzorovanih kliničnih preskušanj antidepresivov pri odraslih bolnikih s psihiatričnimi motnjami je pokazala, da pri bolnikih, mlajših od 25 let, pri uporabi antidepresivov obstaja večje tveganje za pojav samomorilnega vedenja kot pri uporabi placeba.
A meta-analysis of placebo- controlled clinical trials of antidepressants in adult patients with psychiatric disorders showed an increased risk of suicidal behaviour with antidepressants compared to placebo, in patients less than 25 years old.
Metaanaliza s placebom nadzorovanih kliničnih preskušanj antidepresivov pri odraslih bolnikih s psihiatričnimi motnjami je pokazala, da pri bolnikih, mlajših od 25 let, pri uporabi antidepresivov obstaja večje tveganje za pojav samomorilnega vedenja kot pri uporabi placeba.
A meta-analysis of randomised placebo controlled trials of anti-epileptics has also shown a small increased risk of suicidal ideation and behaviour.
Majhno povečanje tveganja za pojav samomorilnega razmišljanja in vedenja je pokazala tudi metaanaliza randomiziranih, s placebom nadzorovanih kliničnih preskušanj antiepileptikov.
A meta-analysis of randomised placebo-controlled trials of anti- epileptic medicinal products has also shown a small increased risk of suicidal ideation and behaviour.
Majhno povečanje tveganja za pojav samomorilnega razmišljanja in vedenja je pokazala tudi metaanaliza randomiziranih s placebom nadzorovanih kliničnih preskušanj antiepileptikov.
A meta-analysis of randomised placebo-controlled trials of anti- epileptic medicinal products has also shown a small increased risk of suicidal ideation and behaviour.
Meta-analiza randomiziranih, s placebom kontroliranih preskušanj antiepileptičnih zdravil je pokazala tudi majhno povečanje tveganja za samomorilne misli in vedenje.
A meta-analysis of randomized placebo- controlled trials of AEDs has also shown a small increased risk of suicidal ideation and behaviour.
Majhno povečanje tveganja za pojav samomorilnega razmišljanja in vedenja je pokazala tudi metaanaliza randomiziranih s placebom, nadzorovanih preskušanj antiepileptikov.
A meta-analysis of randomized placebo- controlled trials of AEDs has also shown a small increased risk of suicidal ideation and behaviour.
Majhno povečanje tveganja za pojav samomorilnega razmišljanja in vedenja je pokazala tudi metaanaliza randomiziranih, s placebom nadzorovanih preskušanj antiepileptikov.
A meta-analysis showed a statistically significant lower rate of both clinical heart failure (RR = 0.20, p=0.02) and clinical and subclinical heart failure combined (RR = 0.38, p<0.0001) in patients treated with Myocet versus conventional doxorubicin.
Metaanaliza je pokazala statistično značilen manjši delež kliničnega popuščanja srca (RT = 0,20, p = 0,02) ter kombinacije kliničnega in subkliničnega popuščanja srca (RT = 0,38, p < 0,0001) pri bolnicah, ki so se zdravile z zdravilom Myocet, v primerjavi s tistimi, ki so dobivale običajni doksorubicin.
A meta-analysis showed a statistically significant lower rate of grade 4 neutropenia (RR = 0.82, p=0.005) in patients treated with Myocet versus conventional doxorubicin.
Metaanaliza je pokazala statistično značilen manjši delež nevtropenije 4. stopnje (RT = 0,82, p = 0,005) pri bolnicah, ki so se zdravile z zdravilom Myocet, v primerjavi s tistimi, ki so dobivali običajni doksorubicin.
A meta-analysis showed a statistically significant lower rate of nausea/vomiting grade  3 (RR = 0.65, p=0.04) and diarrhoea grade  3(RR = 0.33, p=0.03) in patients treated with Myocet versus conventional doxorubicin.
Metaanaliza je pokazala statistično značilen manjši delež navzee/bruhanja stopnje  3 (RT = 0,65, p = 0,04) in diareje stopnje  3 (RT = 0,33, p = 0,03) pri bolnicah, ki so se zdravile z zdravilom Myocet, v primerjavi s tistimi, ki so dobivale običajni doksorubicin.
A method other than oral contraceptives should be used in women of childbearing potential (see sections 4.4 and 4.5).
Ženske v rodni dobi morajo uporabiti drugo metodo kontracepcije, kot pa je peroralna (glejte poglavji 4.4 in 4.5).
A mild and transient increase in body temperature ( 1 °C) has been observed very commonly in clinical studies for a few days after vaccination, with some pups showing less activity and/or a reduced appetite.
Rahlo in prehodno povišanje telesne temperature ( 1°C), ki je trajalo nekaj dni po cepljenju, so zelo pogosto opazili v kliničnih študijah , nekateri mladiči so bili manj aktivni in/ali so imeli zmanjšan apetit.
A mild and transient increase in body temperature ( 1°C) has been observed very commonly in clinical studies for a few days after vaccination, with some pups showing less activity and/or a reduced appetite.
Rahlo in prehodno povišanje telesna temperature ( 1°C), ki je trajalo nekaj dni po cepljenju, so zelo pogosto opazili v kliničnih študijah, nekateri mladiči so bili manj aktivni in/ali so imeli zmanjšan apetit.
A mild and transient increase in body temperature ( 1°C) has been observed very commonly in clinical studies for a few days after vaccination, with some pups showing less activity and/or a reduced appetite.
Rahlo in prehodno povišanje telesne temperature ( 1°C), ki je trajalo nekaj dni po cepljenju, so zelo pogosto opazili v kliničnih študijah, nekateri mladiči so bili manj aktivni in/ali so imeli zmanjšan apetit.
A mild elevation in plasma creatinine and cholesterol levels has been observed in dogs treated with imepitoin; however these did not exceed the normal reference ranges and were not associated with any clinically significant observations or events.
Pri psih, zdravljenih z imepitoinom, so opazili blago zvišanje plazemskega kreatinina in ravni holesterola; vendar pa niso prekoračile normalnih referenčnih razponov in niso bile povezane z nobenimi klinično značilnimi opažanji ali dogodki.
A mild eye/mucosal irritation potential of rivastigmine was identified in a rabbit study.
V študiji na kuncih so ugotovili, da rivastigmin lahko povzroča blago draženje oči oziroma sluznic.
A mild soap is recommended when bathing or showering.
Za kopanje ali prhanje priporočamo uporabo blagega mila.
A minimum of 1 - 2 mm2 of undamaged limbus is required for biopsy.
Za biopsijo mora biti ohranjenega vsaj 1 – 2 mm2 nepoškodovanega limbusa.
A minimum of 500k counts should be collected for optimal images.
Za optimalne slike mora biti število rezultatov najmanj 500 k.
A minor infection such as a cold should not be a problem, but talk to your doctor first.
Blažja okužba kot je na primer prehlad, ne bi smela biti težava, vendar se pred cepljenjem vseeno pogovorite z zdravnikom.
A minor infection such as a cold should not be a problem, but talk to your doctor first. if your child has any known allergies.
Blažje okužbe, kot na primer prehlad običajno ni ovira, vendar se pred cepljenjem vseeno pogovorite z zdravnikom; če ima vaš otrok katero koli znano alergijo (preobčutljivost).
A minor infection such as a cold should not be a problem, but talk to your doctor first. if your child has diarrhoea or is vomiting.
Blažja okužba, kot je npr. prehlad, ne bi smela biti težava, vendar se pred cepljenjem vseeno pogovorite z zdravnikom; če ima drisko ali bruha.
A minor infection such as a cold should not be a problem, but talk to your doctor first. your child has diarrhoea or is vomiting.
Blaga okužba, kot je prehlad, ni ovira, vendar se prej posvetujte z zdravnikom. če ima drisko ali če bruha.
A minor infection such as a cold should not be a problem, but your doctor or nurse should advise whether you could still be vaccinated with Prepandemic Influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics;
Blaţja okuţba kot je prehlad ne predstavlja teţave, vendar vam bosta zdravnik ali medicinska sestra svetovala, ali se lahko še vedno cepite s cepivom Prepandemic Influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics,
A minor infection such as a cold should not be a problem, but your doctor should advise whether you could still be vaccinated with PANDEMIC INFLUENZA VACCINE H5N1 BAXTER; if you have had any allergic reaction, to any ingredient contained in the vaccine (see section 6 at the end of the leaflet) or to formaldehyde, benzonase or sucrose.
Manjša okužba, kot je na primer prehlad, po navadi ni težava, kljub temu pa poslušajte nasvet zdravnika glede cepljenja s cepivom PANDEMIC INFLUENZA VACCINE H5N1 BAXTER; če ste imeli alergijsko reakcijo na katerokoli sestavino cepiva (glejte poglavje 6 na koncu navodila za uporabo) ali na formaldehid, Benzonazo ali saharozo.
A minor infection such as a cold should not be problem, but your doctor should advise whether you could still be vaccinated with VEPACEL. if you have had any allergic reaction to any ingredient of the vaccine (see section 6 at the end of the leaflet) or trace residues (formaldehyde, benzonase, sucrose, trypsin, Vero host cell protein).
Manjša okužba, kot je na primer prehlad, po navadi ni težava, kljub temu pa poslušajte nasvet zdravnika glede cepljenja s cepivom VEPACEL. če ste v preteklosti imeli alergijsko reakcijo na katero koli sestavino cepiva (navedene v poglavju 6 na koncu navodila za uporabo) ali ostanek, ki je morda prisoten v sledeh (formaldehid, benzonaza, saharoza, tripsin, beljakovine gostiteljskih celic Vero).
A missed dose should be omitted if the remaining time is below 6 hours prior to the next due dose.
Če je do naslednjega odmerka manj kot 6 ur, je treba pozabljeni odmerek izpustiti.
A moderate amount of data on pregnant women (between 300 – 1,000 pregnancy outcomes) indicate no malformations or foetal/neonatal toxicity associated with emtricitabine and tenofovir disoproxil.
Manjše število podatkov pri nosečnicah (med 300 in 1.000 izpostavljenih nosečnosti) ne kaže na malformacije ali feto/neonatalno toksičnost povezane z emtricitabinom in dizoproksiltenofoviratom.
A moderate amount of data on pregnant women (between 300-1,000 pregnancy outcomes) indicate no malformations or foetal/neonatal toxicity associated with emtricitabine and tenofovir disoproxil fumarate.
Manjše število podatkov pri nosečnicah (med 300 in 1.000 izpostavljenih nosečnosti) ne kaže na malformacijes ali feto/neonatalno toksičnost povezane z emtricitabinom in dizoproksiltenofovirijevim fumaratom.
A moderate amount of data on pregnant women (between 300-1,000 pregnancy outcomes) indicate no malformations or foetal/neonatal toxicity associated with emtricitabine.
Manjše število podatkov pri nosečnicah (med 300 in 1.000 izpostavljenih nosečnosti) ne kaže na malformacijes ali feto/neonatalno toksičnost povezane z emtricitabinom.
A moderate amount of data on pregnant women (between 300-1,000 pregnancy outcomes) indicate no malformations or foetal/neonatal toxicity associated with tenofovir disoproxil fumarate.
Manjše število podatkov pri nosečnicah (med 300 in 1.000 izpostavljenih nosečnosti) ne kaže na malformacije ali feto/neonatalno toksičnost povezane z dizoproksiltenofovirijevim fumaratom.
A moderate amount of data on pregnant women (between 300-1000 pregnancy outcomes) indicate no malformative or feto/ neonatal toxicity of esomeprazole.
Zmeren obseg podatkov o nosečnicah (od 300 do 1000 izidov nosečnosti) ne kaže, da bi esomeprazol povzročal malformacije, fetotoksične učinke ali toksične učinke na novorojenčka.
A moderate local reaction may occur (pain on palpation, swelling, scratching) that usually disappears spontaneously within 1 week at most.
Lahko se pojavi zmerna lokalna reakcija (bolečina na otip, oteklina in srbenje), ki običajno spontano izgine v največ enem tednu.
A moderate mean increase in total system exposure (AUClast) of up to 1.4-fold was seen in subjects with mild and moderate renal impairment and up to 2.2-fold in subjects with severe renal impairment and end-stage renal disease.
Pri bolnikih z blago oziroma zmerno okvaro ledvic so opažali zmerno povečanje povprečne celotne sistemske izpostavljenosti (AUClast) za največ 1,4-krat, pri bolnikih s hudo okvaro ledvic in končno ledvično odpovedjo pa za največ 2,2-krat.
A modest increase in Cmax (28 %) was observed for zidovudine when administered with lamivudine, however overall exposure (AUC) was not significantly altered.
Opazili so zmerno povečanje vrednosti Cmax (28 %) zidovudina, če so ga uporabili sočasno z lamivudinom, vendar se celotna izpostavljenost (AUC) ni znatno spremenila.
A monoclonal antibody is an antibody (a type of protein) that has been designed to recognise and attach to a specific structure (called an antigen) in the body.
Monoklonsko protitelo je protitelo (vrsta beljakovine), ki je bilo zasnovano tako, da prepozna določeno strukturo (imenovano antigen) telesu in se veže nanjo.
A monoclonal antibody is an antibody (a type of protein) that has been designed to recognise and attach to a specific structure (called an antigen) that is found in certain cells in the body.
Monoklonsko protitelo je protitelo (vrsta beljakovine), ki je bilo zasnovano tako, da prepozna in se veže na določeno strukturo (imenovano antigen), ki se nahaja v nekaterih celicah v telesu.
A monoclonal antibody is an antibody (a type of protein) that has been designed to recognise and attach to a specific structure (called an antigen) that is found in certain cells in the body.
Monoklonsko protitelo je protitelo (vrsta beljakovine), ki je zasnovano tako, da prepoznava specifično strukturo (imenovano antigen) v določenih celicah v telesu in se veže nanjo.
A monoclonal antibody is an antibody (a type of protein) that has been designed to recognise and attach to a specific structure (called an antigen) that is found in certain cells in the body.
To je protitelo (vrsta beljakovine), ki je zasnovano tako, da prepoznava posebno strukturo (imenovano antigen) v določenih celicah v telesu in se veže nanjo.
A monoclonal antibody is an antibody (a type of protein) that has been designed to recognise and attach to a specific structure (called an antigen) that is found in the body.
Monoklonsko protitelo je protitelo (vrsta beljakovine), ki je bilo zasnovano tako, da prepozna določeno strukturo (imenovano antigen) v telesu in se veže nanjo.
A monoclonal antibody is an antibody (a type of protein) that has been designed to recognise and attach to a specific structure (called an antigen) that is found on certain cells in the body.
To je protitelo (vrsta beljakovine), ki je zasnovano tako, da prepozna posebno strukturo (imenovano antigen), ki je prisotna na določenih celicah v telesu, in se veže nanjo.
A monoclonal antibody is an antibody (a type of protein) that has been designed to recognise and attach to vascular endothelial growth factor (VEGF), a protein that circulates in the blood and makes blood vessels grow.
Monoklonsko protitelo je protitelo (vrsta beljakovine), zasnovano tako, da se veže na endotelijski rastni faktor v žilah (VEGF), tj. beljakovino, ki kroži po krvi in omogoča rast krvnih žil.
A monoclonal antibody is an antibody (a type of protein) that has been designed to recognise and bind to a specific structure (called an antigen) that is found in the body.
Monoklonsko protitelo je vrsta protitelesa (vrsta beljakovine), ki je bilo zasnovano za prepoznavanje in vezanje na
A monoclonal antibody is an antibody that has been designed to recognise and attach to a specific structure (called an antigen).
To je protitelo, ki je bilo zasnovano tako, da prepozna posebno strukturo (imenovano antigen) in se veže nanjo.
A more pronounced effect on
Bolj izrazit učinek na
A more pronounced effect on
ugotovi, ali je potrebno odmerek
A more recent report looking at the pattern of mercaptopurine usage in society suggests that there is no increased risk of preterm births, low birth weight at term, or congenital abnormalities in women taking mercaptopurine during pregnancy.
Nedavno poročilo, v katerem so preučevali vzorec uporabe merkaptopurina v družbi, kaže, da ni povečanega tveganja za prezgodnji porod, nizko porodno težo ob predvidenem roku ali prirojenih nepravilnostih pri ženskah, ki so med nosečnostjo jemale merkaptopurin.